Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Rui Yang

1PUBLICATIONS

11CO-AUTHORS

Gene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|May 02, 2025

Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinoma.

Wei-Feng Qu, Gui-Qi Zhu, Rui Yang

Pageof 1

Frequent Collaborators

1 joint publications

Wei-Feng Qu

1 joint publications

Gui-Qi Zhu

1 joint publications

Tian-Hao Chu

1 joint publications

Zhi-Qi Guan

1 joint publications

Qian-Fu Zhao

1 joint publications

Yi-Chao Bu

1 joint publications

Jian Zhou

1 joint publications

Jia Fan

1 joint publications

Wei-Ren Liu

1 joint publications

Zheng Tang

Frequent Collaborators

1 joint publications

Wei-Feng Qu

1 joint publications

Gui-Qi Zhu

1 joint publications

Tian-Hao Chu

1 joint publications

Zhi-Qi Guan

Top Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on : Feb 28, 2019

See more related videos

Top Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on : Feb 28, 2019

See more related videos